Cochlear N1 depression produced by the new “loop” diuretic, bumetanide, in cats
- 31 August 1975
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 14 (8), 547-553
- https://doi.org/10.1016/0028-3908(75)90119-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparison of the cochlear toxicity of sodium ethacrynate, furosemide, and the cysteine adduct of sodium ethacrynate in catsToxicology and Applied Pharmacology, 1975
- Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanideClinical Pharmacology & Therapeutics, 1974
- Cochlear N1 depression produced by the sodium salts of ethacrynic acid and its cysteine adductNeuropharmacology, 1973
- Effects of intra-arterially and intravenously administered ethacrynic acid and furosemide on cochlear N1 in cats*1Toxicology and Applied Pharmacology, 1972
- Structure-activity studies on sulfamyl diureticsJournal of Medicinal Chemistry, 1972
- Bumetanide: Potent New "Loop" DiureticBMJ, 1972
- Aminobenzoic acid diuretics. 2. 4-Substituted-3-amino-5-sulfamoylbenzoic acid derivativesJournal of Medicinal Chemistry, 1971
- Ethacrynic acid and furosemide: Diuretic and hemodynamic effects and clinical usesThe American Journal of Cardiology, 1971
- Evaluation of a new oral diuretic agent. Ethacrynic acid and ethacrynate sodium (Edecrin and Edecrin Sodium)Published by American Medical Association (AMA) ,1969
- Biophysics and Physiology of the Inner EarPhysiological Reviews, 1957